Logo image of ACIU

AC IMMUNE SA (ACIU) Stock Analyst Ratings

USA - NASDAQ:ACIU - CH0329023102 - Common Stock

3.07 USD
0 (0%)
Last: 10/15/2025, 8:12:53 PM
3.03 USD
-0.04 (-1.3%)
After Hours: 10/15/2025, 8:12:53 PM
Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to ACIU. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 9.18. This target is 199.02% above the current price.
ACIU was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ACIU.
In the previous month the buy percentage consensus was at a similar level.
ACIU was analyzed by 9 analysts. More opinions would make the average more meaningful.
ACIU Historical Analyst RatingsACIU Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -106 -96 -86 -76 -66 -56 -46 -36 -26 -16 -6 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 3.077.078.679.1812.60 - 130.29% 182.41% 199.02% 310.42%
ACIU Current Analyst RatingACIU Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-09-08 BTIG Reiterate Buy -> Buy
2025-05-01 HC Wainwright & Co. Maintains Buy -> Buy
2025-04-03 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-18 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-31 BTIG Initiate Buy
2024-03-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-13 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-07 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-28 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-01 HC Wainwright & Co. Reiterate Buy
2023-04-19 HC Wainwright & Co. Reiterate Buy
2023-03-17 HC Wainwright & Co. Reiterate Buy
2022-07-11 SVB Leerink Maintains Outperform
2021-12-20 SVB Leerink Maintains Outperform
2021-03-24 HC Wainwright & Co. Maintains Buy